1 |
Baggio, L. L. and Drucker, D. J. (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157.
DOI
ScienceOn
|
2 |
Holst, J. J. (2007) The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439.
DOI
ScienceOn
|
3 |
Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., Bockaert, J., Bertrand, G. and Dalle, S. (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a -arrestin 1-mediated ERK1/2 activation in pancreatic -cells. J. Biol. Chem. 285, 1989-2002.
DOI
ScienceOn
|
4 |
Doyle, M. and Egan, J. M. (2007) Mechanisms of action of GLP-1 in the pancreas. Pharmacol. Ther. 113, 546-593.
DOI
ScienceOn
|
5 |
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M. and Montminy, M. (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17, 1575-1580.
DOI
ScienceOn
|
6 |
Kodama, S., Toyonaga, T., Kondo, T., Matsumoto, K., Tsuruzoe, K., Kawashima, J., Goto, H., Kume, K., Kume, S., Sakakida, M. and Araki, E. (2005) Enhanced expression of PDX-1 and Ngn3 by exendin-4 during cell regeneration in STZ-treated mice. Biochem. Biophysic. Res. Comm. 327, 1190-1196.
|
7 |
Zhou, J., Chu, J., Wang, Y. H., Wang, H., Zhuang, Y. P. and Zhang, S. L. (2008) Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in pichia pastoris. Biotechnol. Lett. 30, 651-656.
DOI
|
8 |
Gao, Z., Bai, G., Chen, J., Zhang, Q., Pan, P., Bai, F. and Geng, P. (2009) Development, characterization, and evaluation of a fusion protein of a novel glucagon-like peptide-1 (GLP-1) analog and human serum albumin in pichia pastoris. Biosci. Biotechnol. Biochem. 73, 688-694.
DOI
ScienceOn
|
9 |
Oh, J. Y., Lee, C. W., Jang, S. H., Yoo, S. B. and Chung, H. S. (2009) Novel DPP-IV-resistant analogs of GLP-1: The N-terminal extension of GLP-1 by a single amino acid. Bull. Korean Chem. Soc. 30, 2471-2474.
과학기술학회마을
DOI
ScienceOn
|
10 |
Garber, A. J. (2011) Long-acting glucagon-like peptide 1receptor agonists. Diabetes Care 34, S279-S284.
DOI
ScienceOn
|
11 |
Liu, B., Dong, Q., Wang, M., Shi, L., Wu, Y., Yu, X., Shi, Y., Shan, Y., Jiang, C., Zhang, X., Gu, T., Chen, Y. and Kong, W. (2010) Preparation, characterization, and pharmacodynamics of exenatide-loaded poly (DL-lactic-co-glycolic acid) microspheres. Chem. Pharm. Bull. 58, 1474-1479.
DOI
ScienceOn
|
12 |
Huang, Y. S., Chen, Z., Chen, Y. Q., Ma, G. C., Shan, J. F., Liu, W. and Zhou, L. F. (2008) Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris. J. Pept. Sci. 14, 588-595.
DOI
ScienceOn
|
13 |
Kim, B. J., Zhou, J., Martin, B., Carlson, O. D., Maudsley, S., Greig, N. H., Mattson, M. P., Ladenheim, E. E., Wustner, J., Turner, A., Sadeghi, H. and Egan, J. M. (2010) Transferrin fusion technology: A novel approach to prolonging biological half-life of insulinotropic peptides. J. Pharm. Exp. Ther. 334, 682-692.
DOI
ScienceOn
|
14 |
Yeom, J. A., Kim, S. E., Park, H. S., Ham, D. S., Sun C. L, Kim J. W., Cho, J. H., and Yoon, K. H. (2011) Both sitagliptin analogue & pioglitazone preserve the -cell proportion in the islets with different mechanism in non-obese and obese diabetic mice. BMB Rep. 44(11), 713-718.
과학기술학회마을
DOI
ScienceOn
|
15 |
Wang Q, Chen, K., Liu, R., Zhao, F., Gupta, S., Zhang, N. and Prud'homme, G. J. (2010) Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist. PLoS One 5, e12734 1-9.
|
16 |
Bak, E. J., Park, H. G., Lee, C. H., Lee, T. I., Woo, G. H., Na, Y. W., Yoo, Y. J. and Cha, J. H. (2011) Effects of novel chalcone derivatives on α-glucoside, dipeptidyl peptidase-4, and adipocyte differentiation in vitro. BMB Rep. 44, 410-414.
과학기술학회마을
DOI
ScienceOn
|
17 |
Neumiller, J. J. (2009) Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. J. American Pharm. Associ. 49, S16-S29.
DOI
ScienceOn
|
18 |
Chung, H. S., Oh, J. Y., Yoo, S. B., Lee, S. M. and Cho, H. S. (2011) The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice. Regul. Pept. 170, 1-3.
DOI
ScienceOn
|
19 |
Son, Y. K., Hong, D. H., Kim, D. J., Firth, A. L., and Park, W. S. (2011) Direct effect of protein kinase C inhibitors on cardiovascular in ion channels. BMB Rep. 44, 559-565.
과학기술학회마을
DOI
ScienceOn
|
20 |
Baggio, L. L., Huang, Q., Brown, T. J. and Drucker, D. J. (2004) A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53, 2492-2500.
DOI
ScienceOn
|